Publications by authors named "R S Tibbetts"

Objective: To describe the effect of a (SM) respiratory culture nudge on antibiotic use in colonized patients.

Design: IRB-approved quasi-experiment.

Setting: Five acute-care hospitals in Michigan.

View Article and Find Full Text PDF

RIF1 (RAP1 interacting factor) fulfills diverse roles in DNA double-strand break repair, DNA replication, and nuclear organization. RIF1 is expressed as two splice variants, RIF1-Long (RIF1-L) and RIF1-Short (RIF1-S), from the alternative splicing (AS) of Exon 32 (Ex32) which encodes a 26 aa Ser/Lys-rich cassette peptide in the RIF1 C-terminal domain (CTD). Here we demonstrate that Ex32 inclusion was repressed by DNA damage and oncogenesis but peaked at G/M phase of the cell cycle.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of ceftriaxone versus AmpC-stable therapies (like cefepime and carbapenem) in treating bacteremia caused by certain low-risk Enterobacterales.
  • Researchers analyzed data from hospitalized patients with specific bacteria between 2017 and 2024, focusing on 30-day mortality and other clinical outcomes.
  • Results showed no significant differences in 30-day mortality (9.3% for ceftriaxone vs. 10.1% for AmpC-stable therapies) or other clinical outcomes, suggesting ceftriaxone is as effective as AmpC-stable therapies for these infections.
View Article and Find Full Text PDF

Background: Whole-genome sequencing (WGS) has emerged as an alternative genotyping tool for outbreak investigations in the healthcare setting. We describe the investigation and control of a New Delhi metallo-B-lactamase (NDM)-producing cluster in Southeast Michigan.

Methods: Michigan Bureau of Laboratories identified several closely related NDM-producing isolates with WGS.

View Article and Find Full Text PDF

AmpC β-lactamases are associated with development of ceftriaxone resistance despite initial susceptibility, but the risk of AmpC derepression is not equal among Enterobacterales. The purpose of this study was to evaluate the impact of an AmpC stewardship intervention on the definitive treatment of low- and no-risk Enterobacterales. This was an IRB-approved, single pre-test, post-test quasi-experiment at a 5-hospital system.

View Article and Find Full Text PDF